To obtain hyperimmune serum appropriate for the treatment of filovirus infection, methods were developed to immunize nonsusceptible animals with live Ebola (EBO) virus preparations. Immune plasma with high ELISA and neutralization-specific antibody titers was obtained by multiple immunization of sheep and goats with preparations of live EBO virus. Goat immunoglobulin was prepared by Cohn's method and tested on guinea pigs, using an EBO virus strain that is highly pathogenic for guinea pigs. Prophylaxis with these immunoglobulins within 48 h after infection was effective in challenge experiments, with a log 10 prophylaxis index as high as 1.92 { 0.52. Other studies have shown that equine anti-EBO virus immunoglobulins worked well in baboons. The goat immunoglobulins were also tested in preclinical trials on laboratory animals; after being positively evaluated, they were administered to volunteers in clinical trials for biologic safety and reactivity, and they were administered to researchers suspected of becoming infected with EBO during their experimental work. These immunoglobulins may be useful for the emergency treatment of persons accidentally infected with EBO.
After it was realized in 1976 that Ebola (EBO) virus poses
Materials and Methods a threat to public health, the virus remained a great challenge fully, all attempts to develop effective vaccines against EBO gion). We also used 8ms, a newly selected strain that is pathogenic infection have been unsuccessful [1 -5] . Thus, there is a need for guinea pigs (from the virus collection at Vector; described in for the development of other antiviral preparations, such as [5] ). specific antiviral immunoglobulins, which are conventionally Virus-specific antibodies and antibodies against liver antigen were determined by ELISA as previously described [6, 7] . As used in emergency cases (e.g., to treat accidental infections in antigen, we used purified and concentrated (by ultracentrifugation laboratory workers).
in a sucrose gradient) filtrate of 1% homogenate of liver from Herein, we present the results of protective efficacy studies noninfected guinea pigs and SDS-lysate of EBO virus grown on of anti-EBO virus immunoglobulins that were used to treat Vero cell culture. investigators who were suspected of becoming infected with To measure the neutralization titer, we used newborn outbred EBO virus during their experimental work. We also present mice intracerebrally infected with EBO (in vivo test) or infected data from other Russian researchers on the use of equine antiVero cell monolayers under agar cover (in vitro test) as described EBO virus immunoglobulin in baboons. The data concern the in [8] . Before the cells and animals were infected, the neutralization development of antifilovirus immunoglobulin preparations and reaction was done by incubating 10-fold dilutions of EBO virus are based on the authors' investigations and other investigations with undiluted serum or gamma globulin preparations for 18 h at reported in the Russian literature. 4 -6ЊC. The virus-nonspecific serum mixture served as a control. The neutralization index was determined as the difference between a log 10 virus titer of the experimental and the control data.
A 10% liver homogenate from infected guinea pigs was used to immunize sheep and goats. Animals were usually immunized All animal experiments were done according to the national regulations of two times, with the second immunization done 1-3 months after the Russian Federation, and all animals received anesthesia during painful the first. Occasionally, three immunizations were given. Immune procedures.
blood (500-900 mL) samples were obtained 15-20 days after the 
Results
(strain 8ms) in guinea pigs were determined by titration [10] . These 2 strains were also titrated by a plaque assay as previously
The treatment of EBO hemorrhagic fever with immune human described [8] .
convalescent plasma was first reported by Emond et al. [14] in ization-specific EBO antibody titers we measured were unacHemosorption was performed, using a hemosorbent (FAS; Akrikhin, Moscow), by the vein-venous route through peripheral ceptably low, a finding that was in agreement with previously shoulder veins. A hemosorption rate of 70-80 mL/min was propublished data [2, [4] [5] . Subsequently, we found that sheep and vided by a peristaltic pump (Unirol, Kirishy, Russia); 1-2 vol of goats were completely insensitive to EBO virus, and therefore, circulating blood was passed through the sorbent during each 1- we could use large quantities of live virus for immunization. We used for this purpose. The strain was first selected and characterThe final immunoglobulin preparation was a colorless, virtually ized by M. Smolina at the Vector center [5] . Only batches contransparent liquid, pH 7.0-7.5, with 9%-11% total protein containing VNA with titers ú2.5 log 10 were used in gamma globulin tent, and it was apyrogenic, nontoxic, and sterile. The protein consisted of 90%-98% g-globulin and 2%-10% albumin and apreparations. As a result of fractionation, the concentrations of and b-globulins. The liquid also contained 3.1% remaining etha-VNA were ú3 log 10 in the final immunoglobulin preparations, with EBO. In 2 of the cases, infection with EBO virus was slightly suspected: The persons' hands were injured while washing (using a bleach solution) cages in which EBO-infected animals had died. In a third case, the persons's left fist was IgG2 fraction was less reactive than the other two fractions in anaphylaxis tests.
injured by a syringe used to obtain a blood sample from a monkey that had been infected with EBO-Z 4 days earlier.
The Goat immunoglobulin preparation was tested on guinea pigs for its ability to protect against EBO virus infection. Immunosyringe was treated with bleach for 1 -2 min before the injury. In these 3 cases, the immunoglobulin administration was comglobulin was injected 24, 48, and 72 h before challenge by intraperitoneal inoculation with EBO strain 8mc, which is bined with injections of recombinant a-2-interferon (two times daily for 14 days). The only symptom of illness was a rise in pathogenic for guinea pigs. From the results, it is clear that the prophylactic index was maximal when the interval between temperature to 37.3 -37.5ЊC, probably, because of the injected interferon. immunoglobulin injection and virus inoculation was £24 h (table 2.). Table 3 presents the results of similar experiments
The fourth person with a suspected case of accidental EBO infection was an investigator who pricked his left palm with a in which immunoglobulin was injected after inoculation with virus. In these cases, the results were positive up to 72 h after thick needle during a plasmapheresis procedure on an ill monkey that was infected with EBO-Z. Analysis of blood obtained virus inoculation.
Goat preparations were tested in conformity with national from this monkey on the day of the accident demonstrated the presence of live virus at 7.8 log 10 LD 50 for guinea pigs. Acregulations for preclinical trials (anaphylactogenicity, apyrogenicity, acute and chronic toxicity, tumorigenicity, effects on cording to our calculations, the injured person received a virus dose of at least 10 2 -10 3 baboon LD 50 . This fourth case is hematologic parameters, liver function). Clinical trials on volunteers were started after formal governmental permission was noteworthy because there were other symptoms related to possible EBO infection. given. Goat immunoglobulin was injected into 7 volunteers (treated group), and placebo was given to 3 volunteers (unJust after the injury, the investigator pressed blood from his wound and treated the injury with bleach. He was then referred treated control group).
There were no local or general reactions at the time of the to a hospital, where he received a 6-mL injection of anti-EBO goat immunoglobulin intramuscularly. Recombinant human ainjection or later. Recorded body temperature, blood pressure, and urine parameters were normal. The time course of changes 2-interferon was administered two times daily (3 1 10 6 IU portions) for 12 days. Laboratory studies of 20 biochemical in the number of lymphocytes and neutrophils (segmental and rod) was stable, while the number of monocytes in the treated blood parameters were done daily. Four days after the injury, the serum a-amylase level increased 2-fold. On day 5, the size group rose to the upper limit of the normal value on day 1 after immunoglobulin inoculation and remained unaltered during the of the inguinal lymph nodes and the liver increased by 2 cm. observation period. The number of eosinophils in the treated group was above normal on days 14 and 28. The increase in the number of monocytes and eosinophils was probably due The number of T lymphocytes (percent and absolute value) remained unaltered in both groups of volunteers. The number of erythrocytes and thrombocytes, the hemoglobin concentration, and the activity of alanine aminotransferase, A rise in body temperature (to 37.0 -37.3ЊC) was recorded fense. The work was in parallel and partly independent of our studies. An immunoglobulin preparation from immunized from the first day of injury and was presumably due to the interferon treatment. On day 6, the patient's fibrinogen level horse serum was successfully developed at the Center [3, 16, 17] . The Moscow virologists used a live virus preparation that started to rise, reaching 5.5 g/L (normal, £4); the same was observed for the prothrombin index, which rose to 112% (norwas similar to ours to immunize horses (described in [11]), and they used a similar immunization schedule (described in mal, 100%). The activities of alanine aminotransferase and aspartate aminotransferase also increased. There was erythema [3, 11, 16] ). As a result, they developed immunoglobulin preparations with VNA titers of 1:8000 -1:64000 (see [16] ). Table at the site of the immunoglobulin injection. Symptoms of illness included myalgia, headache, arthralgia, and malaise.
5 presents the first data obtained from tests of equine gamma globulin preparations in P. hamadryas [3] . The preparations On days 8 and 10, a hemosorption procedure was done. All the parameters normalized on day 12 after the injury. The protected baboons against low doses of EBO virus by intramuscular injection). The only fatally infected bapatient's general condition improved, and the symptoms disappeared. The patient recovered, and the virus could not be deboon died after a prolonged incubation period on day 18 after infection, which is quite an unusual course for EBO virus. tected and antibodies were not found in his blood.
A retrospective analysis of his case report revealed a conIn their second and third papers [16, 17] , the Moscow investigators gave a more detailed evaluation of their protective effifounding pattern. The course of changes in biochemical parameters showed that a cytolytic process of unknown etiology was cacy studies of equine gamma globulin in EBO-infected baboons. Pertinent information is given in table 6 (see [16] for developing. Clearly, all the symptoms could not be attributed to EBO infection or to the gamma globulin injection. However, details). The preparation with the highest VNA titers provided ú80% protection against an EBO virus injection of 10 -30 the volunteers showed no similar reactions in trials of the preparation.
LD 50 , and the baboons that were injected with immunoglobulin during the first hour after infection did not develop blood and Similar immunoglobulin technology was developed and protective efficacy studies were done at the Virologic Center of liver viremia. When the interval between virus injection and immunoglobulin inoculation was ú1.0 -1.5 h, the percentage the Institute of Microbiology of the Russian Ministry of Deof baboons that survived was considerably smaller. It should be noted that in this particular case, the incubation period was up to 26 days, which is much longer than the usual 4 -7 days. product in Russia for the emergency treatment of EBO fever. equine anti-EBO immunoglobulin and independently conducted protective efficacy studies (described in [18] ). The re-NOTE. Controls who were given a placebo were also tested: ELISA titers were negative at all times. ND Å not done.
sults obtained in cynomolgus monkeys treated with the immu-/ 9d49$$se17 01-05-99 13:27:00 jinfas UC: J Infect these facts may explain why the equine anti-EBO immunoglobulin preparation is effective when administered shortly (no later infectious doses [18] .
Specific gamma globulin administered early after infection than 1 -2 h) after EBO virus infection. of guinea pigs and hamadryas baboons is effective presumably because small quantities of EBO virus are completely neutralConclusion ized by antibodies in vivo before the virus starts to interact with cell receptors. It is well known that human hyperimmune As detailed here, immunoglobulin preparations have been developed that protect guinea pigs and baboons from infection anti-tickborne encephalitis (TBE) virus immunoglobulin is similarly effective against low doses of TBE virus and that this with fatal doses of EBO virus. Occasionally, medical research investigators, medical personnel, and animal care workers preparation has been successfully used for many years in Austria and Russia for urgent prophylaxis of disease after tick bites.
working with EBO virus in the hospital, laboratory, or jungle are accidentally infected with EBO virus. To our knowledge, As for EBO virus, its presence was first shown in monocytes and macrophages of infected monkeys 48 h after virus inoculathese immunoglobulin preparations are the first that can be 
